Evidence map›Paper›PMID 35326821›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Synthesis Monitoring, Characterization and Cleanup of Ag-Polydopamine Nanoparticles Used as Antibacterial Agents with Field-Flow Fractionation.

Valentina Marassi, Sonia Casolari, Silvia Panzavolta, Francesca Bonvicini, Giovanna Angela Gentilomi, Stefano Giordani, Andrea Zattoni, Pierluigi Reschiglian, Barbara Roda

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Valentina MarassiDepartment of Chemistry G. Ciamician, University of Bologna, 40126 Bologna, Italy.ORCID 0000-0001-8742-3708
Sonia CasolariDepartment of Chemistry G. Ciamician, University of Bologna, 40126 Bologna, Italy.
Silvia PanzavoltaDepartment of Chemistry G. Ciamician, University of Bologna, 40126 Bologna, Italy.
Francesca BonviciniDepartment of Pharmacy and Biotechnology, University of Bologna, 40138 Bologna, Italy.ORCID 0000-0001-8101-9835
Giovanna Angela GentilomiDepartment of Pharmacy and Biotechnology, University of Bologna, 40138 Bologna, Italy.
Stefano GiordaniDepartment of Chemistry G. Ciamician, University of Bologna, 40126 Bologna, Italy.
Andrea ZattoniDepartment of Chemistry G. Ciamician, University of Bologna, 40126 Bologna, Italy.
Pierluigi ReschiglianDepartment of Chemistry G. Ciamician, University of Bologna, 40126 Bologna, Italy.
Barbara RodaDepartment of Chemistry G. Ciamician, University of Bologna, 40126 Bologna, Italy.ORCID 0000-0003-1060-2921
University of Bologna · ITIstituto Nazionale Biostrutture e Biosistemi · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in nanotechnology have opened up new horizons in nanomedicine through the synthesis of new composite nanomaterials able to tackle the growing drug resistance in bacterial strains. Among these, nanosilver antimicrobials sow promise for use in the treatment of bacterial infections. The use of polydopamine (PDA) as a biocompatible carrier for nanosilver is appealing; however, the synthesis and functionalization steps used to obtain Ag-PDA nanoparticles (NPs) are complex and require time-consuming cleanup processes. Post-synthesis treatment can also hinder the stability and applicability of the material, and dry, offline characterization is time-consuming and unrepresentative of real conditions. The optimization of Ag-PDA preparation and purification together with well-defined characterization are fundamental goals for the safe development of these new nanomaterials. In this paper, we show the use of field-flow fractionation with multi-angle light scattering and spectrophotometric detection to improve the synthesis and quality control of the production of Ag-PDA NPs. An ad hoc method was able to monitor particle growth in a TLC-like fashion; characterize the species obtained; and provide purified, isolated Ag-PDA nanoparticles, which proved to be biologically active as antibacterial agents, while achieving a short analysis time and being based on the use of green, cost-effective carriers such as water.

Indexed as

antimicrobialscleanupflow-field flow fractionation multidetectiononline characterization and purificationseparationsilver polydopamine nanoparticlessynthesis monitoring

Identifiers

PMID35326821
PMCPMC8944547
OpenAlexW4220864660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.